Special AT-rich sequence-binding protein 2 (SATB2)-associated syndrome (SAS) is characterized by alterations of SATB2.
| INTRODUCTION
Special AT-rich sequence-binding protein 2 (SATB2)-associated syndrome (SAS) (Döcker et al., 2014 ) is a genetic disorder caused by aberrations of the SATB2 gene; it is characterized by phenotypes that include developmental delay, intellectual disability (ID) with absent or limited speech development, cleft palate, and teeth abnormalities. This syndrome is also known as "Glass syndrome" (OMIM #612313) on the basis of a report of a patient with a deletion in chromosome 2 in 1989 (Glass, Swindlehurst, Aitken, McCrea, & Boyd, 1989) . Other patients with similar phenotypes and deletions in this locus have been reported to have "2q33.1 microdeletion syndrome" or "2q32 deletion syndrome." (Boone et al., 2016; Lee et al., 2016; Leoyklang et al., 2007; Rauch et al., 2012; Zarate et al., 2017; Zarate et al., 2015) . Most human chromosomal aberrations involving SATB2 result in similar phenotypes, including cleft palate, ID, and craniofacial deformities. Thus far, multiple SATB2 mutations have been reported, including singlenucleotide variations (SNVs) and small insertions/deletions (indels) (Boone et al., 2016; Lee et al., 2016; Leoyklang et al., 2007; Rauch et al., 2012; Zarate et al., 2017; Zarate et al., 2015 Zarate et al., , 2018 .
Here, we describe three unrelated patients who had de novo mutations in SATB2; two of the mutations were novel. All three patients exhibited multiple odontomas; this has not been previously described as an SAS phenotype. Although isolated odontomas are a relatively common type of odontogenic tumor, the occurrence of multiple odontomas (i.e., the presence of multiple tumors in one individual) is rare (Philipsen, Reichart, & Praetorius, 1997) . Ide and colleagues listed 34 reports of multiple odontomas of both jaws, published from 1890 to 2014 (Ide, Kikuchi, Miyazaki, Kusama, & Muramatsu, 2016) .
Here, we describe, for the first time, multiple odontomas as a previously unknown clinical phenotype of SAS.
| MATERIALS AND METHODS

| Editorial policies and ethical considerations
Written informed consent for participation in this study was collected from all patients and their family members. The study was approved by the ethics committees of the following institutions: Graduate School of Dental Medicine and Faculty of Pharmaceutical Science, Hokkaido University; Aichi Gakuin University; and Nagasaki University.
| Sample collection and DNA extraction
Genomic DNA was isolated from peripheral white blood cells using conventional proteinase K digestion and phenol-chloroform methods, combined with dialysis purification.
| Massively parallel sequencing and Sanger sequencing
For whole-exome sequencing (WES), genomic DNA samples from the subjects were enriched with SureSelect Human whole exome V5 (Agilent Technologies, Santa Clara, CA, in accordance with the manufacturer's protocol. The prepared libraries were sequenced with a HiSeq2500 (Illumina, San Diego, CA). For amplicon sequencing, Ion AmpliSeq Designer (Thermo Fisher Scientific, Waltham, MA) was used to design the multiplex PCR primers for amplification of all exons of SATB2. The SATB2 amplicons were generated in accordance with the manufacturer's instructions; they were then sequenced with the Ion Proton™ Sequencer (Thermo Fisher Scientific). Sanger sequencing was performed with BigDye terminator reagents and run on a 3130xl
Genome Analyzer (Thermo Fisher Scientific) (Supporting Information S1).
| Sequencing data analysis
NovoAlign software (Novocraft, Petaling Jaya, Malaysia) was used to map reads on the hg19/GRCh37 human reference genome sequence.
The Genome Analysis Toolkit (GATK) (McKenna et al., 2010) was used for variant calling (GATK HaplotypeCaller) with an in-house workflow management tool (Mishima, Sasaki, Tanaka, Tatebe, & Yoshiura, 2011) . For family trios, de novo SNVs and indels were selected by using the following criteria: a patient was not a reference allele homozygote, and both parents were not alternative allele homozygotes.
Finally, the ANNOVAR software package (Wang et al., 2010) was used to annotate the selected SNVs and indels. "Rare deleterious" mutations were defined as those that met the following criteria: (a) they led to a stop-gain, stop-loss, nonsynonymous, or splice-site mutation; (b) their alternative allele frequencies were each equal to or <0.5% in the Complete Genomics 69 whole-genome sequence dataset (Drmanac et al., 2010) , 1,000 genome project dataset (The 1000 Genomes Project Consortium, 2010), and the Human Genomic Variation Database (HGVD) (Higasa et al., 2016) exome data of 1,208 individuals collected in Japan; and (c) they were not included in segmental duplication regions in the UCSC Genome Browser (https://genome. ucsc.edu/). As a representative SATB2 splicing variant for this analysis, we selected an mRNA identified by accession numbers RefSeq NM_001172517 and ENSEMBL ENST00000260926.5.
| Histopathology
Teeth and odontomas were decalcified in 5% ethylenediaminetetraacetic acid (EDTA) in PBS (pH 7.4) for 2 months. Samples were paraffin-embedded, sectioned at a thickness of 5 μm, and then stained with hematoxylin and eosin (HE).
| Cell culture and SATB2 expression analysis
Dental pulp tissues were collected from teeth extracted from Patient 2 and two healthy volunteers and then cultured as described previously (Gronthos, Mankani, Brahim, Robey, & Shi, 2000) . Briefly, dental pulp tissue was separated from a remnant crown and then digested in phosphate-buffered saline (PBS) containing 3 mg/mL collagenase type I (Worthington Biochemicals, Lakewood, NJ) for 30 min at 37 C.
Single-cell suspensions were seeded into six-well plates (Costar, Cambridge, MA) with alpha-Modified Eagle's Medium (Invitrogen, Waltham, MA) supplemented with 15% fetal calf serum (Invitrogen), 100 μM l-ascorbic acid 2-phosphate (WAKO Pure Chemical Industries, Ltd., Richmond, VA), 2 mM l-glutamine (Invitrogen), 100 U/mL penicillin, and 100 μg/mL streptomycin (Invitrogen), then incubated at 37 C in 5% CO 2 .
Total RNA was extracted from dental pulp cells using TRIzol reagent (Thermo Fisher Scientific), in accordance with the manufacturer's instructions. First-strand cDNA was synthesized using a Revatra Ace FSK 101 kit (Toyobo Co., Ltd., Osaka, Japan). The reaction buffer contained the following components: 50 mM Tris HCl (pH 7.5), 100 mM NaCl, 0.1 mM EDTA, 10 mM dithioerythritol, 0.01% Nonidet 3 | RESULTS Table 1 shows a summary of the clinical features of the three patients included in this study, as well as patients from previous reports.
| Case reports
Details of the dental abnormalities observed in these three patients are described in Table 1 .
Patient 1 was a 19-year-old female who was the second child of healthy nonconsanguineous parents. Compared with her healthy 23-year-old sister (Sibling 1), she exhibited a severe delay in speech development; expressive speech was almost absent. She also exhibited facial dysmorphism that included a bulbous nose and a small mouth, short philtrum and micrognathia with a long, narrow face. At birth, after an uncomplicated pregnancy, she had isolated cleft palate and micrognathia. The cleft palate was repaired at 6 months of age (arrow in Figure 1a ). Panoramic radiography showed various dental developmental abnormalities, including delayed tooth eruption, macrodontia, and abnormal root shape (Figure 1d ). The mandibular and maxillary tooth lengths of Patient 1 were shorter than those of Sibling 1. Computed tomography (CT) images, as well as panoramic radiography, showed odontoma-like radiopaque lesions at teeth 17 and 27 (Figure 1d ,g,h).
Patient 2 was a 19-year-old female who presented with a chief complaint of spontaneous sharp pain emanating from the maxillary right quadrant. An intraoral examination revealed that tooth 16 exhibited extensive distal caries. She was the first child of healthy nonconsanguineous parents. There was no significant family history, and she was born after a normal pregnancy. At birth, she exhibited an isolated cleft palate that was repaired at 6 months of age (arrow in Figure 1b ). Tooth 16 was extracted when she was 13 years old. The extracted tooth showed distinct morphologic features with a columnar body and skirt-like root shape (Figure 2d,f ) . Several denticles were also observed, which are common in elderly individuals but rare at 13 years of age (Figure 2g ). Histological analysis revealed characteristic structural malformations of the dentin (Figure 2g,j) . The dentinal tubules of Patient 2 were interrupted in the middle of the coronal dentin (yellow arrowheads in Figure 2j) , and a portion of the dentinal tubules exhibited a spiral shape (Figure 2j ). Cavities lined with epithelial cells were also observed in the root dentin (white arrows in Figure 2h ).
Patient 3 was a 16-year-old male who was the first child of healthy nonconsanguineous parents. His 14-year-old sister did not exhibit any remarkable clinical features. The pregnancy was uneventful and isolated cleft palate was observed in the patient at the time of birth; it was surgically corrected at the age of 1 year and 11 months (arrow in Figure 1c) . By the age of 6 years, the patient 
| Molecular analyses
De novo heterozygous mutations were observed upon WES in Mutation positions are per the hg19/GRCh37 human reference genome sequence, and the NM_001172517 and ENST00000260926.5 transcript sequence. Specific teeth are indicated using the FDI dental notation. 
| DISCUSSION
The three patients included in this study shared similar clinical features that were consistent with previously described features of SAS. These features included severe ID, prominent nose, micrognathia, cleft palate, and morphological abnormalities of the teeth. To the best of our knowledge, this is the first study to describe patients with SAS exhibiting characteristic multiple odontomas, which are benign tumors of odontogenic origin that are most frequently observed in the jaw. Odontomas comprise two specific forms: (a) compound odontomas that form multiple small tooth-like structures and (b) complex odontomas that form an amorphous calcified mass. Although isolated odontomas are a relatively common type of odontogenic tumor, multiple odontomas are rare (Philipsen et al., 1997) . Moreover, the occurrence of both complex and compound odontomas in the same individual is extremely uncommon (Mani, 1974) . Odontomas are developmental anomalies that result from the growth of fully differentiated epithelial and mesenchymal cells, as indicated by calcified dental tissues of both epithelial and mesenchymal origin. The exact pathogenesis of odontomas remains unknown. In addition, the molar teeth of the three patients exhibited globodontia with enlarged crowns, large pulp chamber, short roots, and pulp stones. These findings indicated that the cause of the abnormal morphology and multiple odontomas may occur during the early period of tooth development.
The SATB2 gene was originally identified as a causative gene for cleft palate (Brewer et al., 1999) . It was recently proposed that the loss of SATB2 function causes SAS. SATB2 is located on chromosome 2q33.1 and encodes a protein comprising 733 amino acids with two DNA-binding CUT domains (FitzPatrick et al., 2003) .
SATB2 encodes a cell type-specific transcription factor, which binds to nuclear matrix attachment regions that regulate the expression of multiple genes (Dobreva, Dambacher, & Grosschedl, 2003) .
Histological analysis of mice revealed that Satb2 is expressed in developing jaw primordia, brain, skeleton, and developing molar teeth (Britanova et al., 2006; Dobreva et al., 2006) . Previous studies in mice showed that complete functional loss of Satb2 led to apoptosis in the developing jaw primordia, followed by downregulation of the expression of Pax9, Alx4, and Msx genes, which are involved in craniofacial development in mice and humans (Britanova et al., 2006; Park et al., 2006) . Animal studies have revealed an essential role for Satb2 in craniofacial bone and cerebral cortex development (Alcamo et al., 2008) .
Odontogenesis may be explained by several molecular pathways related to SATB2, including sonic hedgehog (Shh), runt-related transcription factor (RUNX) 2, and bone morphogenetic protein (BMP)
4. The Shh signaling pathway is required for the development of early tooth formation and is exclusively expressed in the epithelial compartment during early tooth development. It regulates crown width and cusp formation of teeth (Dassule, Lewis, Bei, Maas, & McMahon, 2000) . This pathway has been shown to mediate the expression of satb2 in zebrafish (Sheehan-Rooney, Swartz, Lovely, Dixon, & Eberhart, 2013) . RUNX2 has a primary role in the differentiation of osteoblasts and hypertrophy of cartilage in the growth plate (Cohen, 2009 ).
Heterozygous mutations of RUNX2 have been shown to cause cleidocranial dysplasia (Mundlos et al., 1997) , characterized by craniofacial malformation and dental abnormalities (Mundlos et al., 1997) including delayed eruption and impaction of multiple supernumerary teeth (Chopra et al., 2012) . Analysis of Satb −/− mice has revealed that SATB2 directly interacts with and enhances the activity of RUNX2 which plays an important role in tooth development (Xu et al., 2008) .
Odontomas and supernumerary teeth share a tissue origin and odontogenic process (Pippi, 2014) .
We detected SATB2 expression in mesenchymal cell lines derived This study examined the histopathological details of disturbed odontogenesis in patients with SAS. Normal dentinal tubules exhibit a natural sigmoid course primary curvature, whereas those of Patient 2 were irregularly curved. The continuity of the dentinal tubule was ruptured and multiple dentinal tubules were fused. These observations, as well as the presence of multiple denticles, suggest that SATB2 plays an important role in dentinogenesis by odontoblasts.
Moreover, such structural abnormalities of dentin may result in extensive dental caries.
In conclusion, this study has described the clinical and molecular com/ac) for editing a draft of this manuscript.
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